SS

Sanjith Saseedharan

Active Director Director DIN 11021987
DIN 11021987 First appointment Apr 2025 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Sanjith Saseedharan

Data last updated:

Sanjith Saseedharan is a Director at Consigliere Healthcare Private Limited (since 2025). The company operates in Healthcare.

DIN 11021987
Primary Designation Director
Industry Healthcare
First Appointment 03 Apr 2025
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Apr 20252021Active

Directorship timeline

Open interactive timeline →
Consigliere Healthcare Private Limited
Premium access

Shareholding and investment profile for Sanjith Saseedharan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjith Saseedharan

Sanjith Saseedharan currently holds 1 directorship: Consigliere Healthcare Private Limited (Director, since 03 Apr 2025).

Sanjith Saseedharan was first appointed on 03 Apr 2025 as Director at Consigliere Healthcare Private Limited.

The current boards of Sanjith Saseedharan's companies include Amit Balai Chakraborty (Consigliere Healthcare Private Limited), Gauravkumar Rajiv Mishra (Consigliere Healthcare Private Limited), Varun Sharadchandra Tripathi (Consigliere Healthcare Private Limited), Vikramaditya Prakash Salvi (Consigliere Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available